Pfizer Inc., the world’s biggest drugmaker with operations in Groton, said Thursday it invested $100 million in the expansion of its Singapore plant that makes nutritional products for infants and children, The Associated Press reports.
The New York company said the expansion increased the plant’s production capacity by 50 percent. That helps it serve several Asian countries, including China, Indonesia, Thailand, Taiwan and Vietnam.
The plant was a Wyeth operation acquired in Pfizer’s purchase of Wyeth last fall.
The expansion of the plant, which is now part of Pfizer Global Manufacturing’s Nutrition Operating Unit, brings the total investment in the facility to $372 million.
